James Rowley, MD, of Rush University System for Health, says napping for 15–20 minutes can refresh, but taking frequent naps hints at poor sleep.
The AMA collaborates on a tool to identify inequities in access, coverage and payment for mental health and substance-use services.
The AMA’s Physician Well-Being Program aims to raise awareness, advance knowledge and catalyze change to reduce burnout. Learn more with the AMA.
Find information on what the CPT code set is and why CPT codes are integral to health care innovation.
Opioids can be an effective treatment for chronic pain, but prescribing them properly requires prudence. Learn more with the AMA.
A framework for educators and administrators who create programs for coaching medical students—view videos, purchase books or download directories of workshop participants.
When writing your personal statement, veteran residency program directors said that authenticity will trump AI every time. ChatGPT agrees.
For Bo Hrom, MD, of Hattiesburg Clinic, the emotional toll of treating cancer patients is offset by the reward of improving their lives.
Most physicians practice where they completed residency, but not all. Learn which specialties and states are most likely to keep you local.
It wasn’t easy for AMA member Daniel E. Choi, MD, to start his physician private practice. He wishes he’d known that it would turn out OK. Learn more.
AMA-led federation letters oppose federal bill expanding pharmacists’ scope of practice and more in the latest National Advocacy Update.
Federal health research tackles kidney disease and more in the latest National Advocacy Update.
This two-day boot camp, Sept. 17-18, 2025, will equip attendees with the time-saving tools and strategies to reform their organizations and enhance professional satisfaction.
ChangeMedEd® is a national conference that brings together leaders and innovators to accelerate change in medical education across the continuum. Learn more.
Download and review the PDF list of pending reports from the Board and the councils, and submit comments and feedback.
Make travel arrangements for the Interim Meeting of the HOD taking place Nov. 14-18, 2025 at the Gaylord National Resort & Convention Center in National Harbor, Maryland.
Download PDFs of reports from the Council on Medical Education presented during the AMA Annual and Interim Meetings.
Download PDFs of reports on this topic from the Council on Medical Education presented during the AMA Interim and Annual Meetings.
View candidates for upcoming elections for the Underrepresented in Medicine Advocacy Section (UMAS) Governing Council.
Find the agenda PDF, documents and more for the 2025 APS Interim Meeting on Nov. 13 at the Gaylord National Resort & Convention Center, National Harbor, Maryland.
In the news: Measles cases surge in the Americas, COVID accelerates vascular aging and more.
From alopecia areata to seborrheic dermatitis, these patient-friendly tools make it easier for you to explain dermatological conditions.
The opioid epidemic affects the lives of millions of Americans. Find out how the AMA is leading the fight against opioid addiction in America.
The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.
CMS issues new guidance on PHE unwinding, including important implications for audio-only services and more in the latest National Advocacy Update.
Sentara Healthcare becomes latest system to update credentialing questions and more in the latest State Advocacy Update.
The last time the U.S. experienced a two-year decline in life expectancy was during World War II. Three physicians share more about life expectancy.
Read media highlights mentioning the American Medical Association for February 2023.
FDA advisory panels vote 19-0 in favor of OTC naloxone and more in the latest National Advocacy Update.
Georgia medical board updates licensing application to support physician wellness and more in the latest State Advocacy Update.
Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.
Buprenorphine prescribing now available to all DEA-registered physicians and more in the latest Advocacy Update spotlight.
